Marshall Wace’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-103,490
| Closed | -$7.05M | – | 3605 |
|
|
2022
Q3 | $7.05M | Buy |
103,490
+1,679
| +2% | +$114K | 0.02% | 1010 |
|
|
2022
Q2 | $3.25M | Buy |
+101,811
| New | +$3.25M | 0.01% | 1390 |
|
|
2022
Q1 | – | Sell |
-80,042
| Closed | -$2.34M | – | 4061 |
|
|
2021
Q4 | $2.34M | Buy |
80,042
+50,735
| +173% | +$1.49M | ﹤0.01% | 1560 |
|
|
2021
Q3 | $747K | Buy |
+29,307
| New | +$747K | ﹤0.01% | 1690 |
|
|
2020
Q4 | – | Sell |
-133,872
| Closed | -$7.38M | – | 2176 |
|
|
2020
Q3 | $7.38M | Sell |
133,872
-87,914
| -40% | -$4.85M | 0.05% | 364 |
|
|
2020
Q2 | $14M | Buy |
+221,786
| New | +$14M | 0.1% | 198 |
|
|
2017
Q1 | – | Sell |
-724,024
| Closed | -$10.5M | – | 834 |
|
|
2016
Q4 | $10.5M | Buy |
+724,024
| New | +$10.5M | 0.07% | 322 |
|